盧 孟良

Medicine & Life Sciences

1. Schizophrenia 100%
2. Olanzapine 70%
3. Antipsychotic Agents 56%
4. Clozapine 50%
5. Antidepressive Agents 37%
6. Cohort Studies 34%
7. Bipolar Disorder 31%
8. Depression 30%
9. Population 30%
10. Metabolic Syndrome 29%
11. Major Depressive Disorder 27%
12. desmethylolanzapine 24%
13. Psychotic Disorders 21%
14. Fluvoxamine 21%
15. Psychiatry 19%
16. Post-Traumatic Stress Disorders 18%
17. Earthquakes 18%
18. Meta-Analysis 16%
19. Metformin 16%
20. Adiponectin 15%
21. Weight Gain 15%
22. Therapeutics 14%
23. Unsaturated Fatty Acids 14%
24. Psychopathology 14%
25. Risperidone 14%
26. Ghrelin 13%
27. Placebos 13%
28. Anxiety 13%
29. Quetiapine Fumarate 12%
30. Mood Disorders 12%
31. Insulin Secretion 12%
32. Serotonin Uptake Inhibitors 11%
33. National Health Programs 11%
34. Lithium 11%
35. Hyperprolactinemia 11%
36. Wounds and Injuries 11%
37. Firefighters 10%
38. Citalopram 9%
39. Treatment-Resistant Depressive Disorder 9%
40. Protective Agents 9%
41. Genes 9%
42. Depressive Disorder 9%
43. Orexins 9%
44. Case-Control Studies 9%
45. Serum 9%
46. Smoking 9%
47. Alleles 9%
48. Databases 9%
49. Omega-3 Fatty Acids 8%
50. Hepatocellular Carcinoma 8%